In fact, we have recently demonstrated important role of Vimentin/Slug EMT markers in tumor growth of primary breast cancer patients and in circulating tumor cells (CTCs) EGFR+ from cytokeratin negative non-metastatic breast cancer patients39. This evidence concerns the gene VIM and breast cancer.